TransMedics Group, Inc. (TMDX)

NASDAQ: TMDX · IEX Real-Time Price · USD

148.97

-1.22 (-0.81%)

At close: Jul 2, 2024, 4:00 PM

149.80

+0.83 (0.56%)

After-hours: Jul 2, 2024, 7:58 PM EDT

TransMedics Group Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2016
Net Income	-25.03	-36.23	-44.22	-28.75	-33.55	Upgrade
Depreciation & Amortization	9.22	4.2	2.65	1.58	1.22	Upgrade
Share-Based Compensation	19.79	10.32	6.88	2.41	0.85	Upgrade
Other Operating Activities	-17.01	-24.1	5.83	-5.51	-0.82	Upgrade
Operating Cash Flow	-13.03	-45.82	-28.86	-30.27	-32.29	Upgrade
Capital Expenditures	-151.85	-11.91	-3.52	-0.46	-0.17	Upgrade
Acquisitions	-42.11	0	0	0	0	Upgrade
Change in Investments	0	66.42	32.79	-41.14	-60.34	Upgrade
Investing Cash Flow	-193.95	54.51	29.27	-41.6	-60.5	Upgrade
Share Issuance / Repurchase	7.11	145.47	1.39	75.55	97.57	Upgrade
Debt Issued / Paid	393.31	22.46	0	0	0	Upgrade
Other Financing Activities	-	-	-	-	-4.85	Upgrade
Financing Cash Flow	400.42	167.93	1.39	75.55	92.72	Upgrade
Exchange Rate Effect	0.19	-1.02	-0.8	0.8	-0.09	Upgrade
Net Cash Flow	193.63	175.6	1	4.49	-0.15	Upgrade
Free Cash Flow	-164.88	-57.72	-32.38	-30.72	-32.45	Upgrade
Free Cash Flow Margin	-68.24%	-61.76%	-107.01%	-119.82%	-137.48%	Upgrade
Free Cash Flow Per Share	-5.07	-1.95	-1.17	-1.24	-2.29	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).